July 17, 2024

Animal Model Market Size to Rake USD 5.72 Billion by 2033

The global animal model market size was estimated to be around US$ 2.48 billion in 2023 and is projected to reach US$ 5.72 billion by 2033, indicating a CAGR of 8.71% from 2024 to 2033.

Key Points

  • North America led the market with the largest market share of 50% in 2023.
  • By application type, the cancer segment has held the largest market share of 44% in 2023.
  • By animal type, the mice & rat segment held the largest share of 53% in 2023.
  • By end use, in 2023, the pharmaceutical & biotechnology companies segment has captured more than 40% of market share in 2023.

Animal Model Market Size 2024 to 2033

The market research report on the animal model market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of animal model products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3890

Animal Model Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 8.71%
Global Market Size in 2023 USD 2.48 Billion
Global Market Size by 2033 USD 5.72 Billion
U.S. Market Size in 2023 USD 0.93 Billion
U.S. Market Size by 2033 USD 2.15 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Application, By Animal Type, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Recombinant Antibodies Market Size to Rise USD 23.34 Bn by 2033

The report presents the volume and value-based market size for the base year 2023 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global animal model market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the animal model market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of animal model products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2024 to 2033. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the animal model market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the animal model market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Animal Model Market Companies

  • Charles River Laboratories
  • The Jackson Laboratory
  • genOway
  • Taconic Biosciences, Inc.
  • Janvier Labs
  • Harbour BioMed
  • Crown Bioscience
  • Inotiv
  • BIOCYTOGEN
  • BioSpherix, Ltd.

Segments Covered in the Report

By Application

  • Cancer
  • Immunological Disease
  • Infectious Disease
  • Others

By Animal Type

  • Mice
  • Rat
  • Guinea Pigs
  • Rabbits
  • Hamsters
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institute
  • Contract Research Organization

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Model Market 

5.1. COVID-19 Landscape: Animal Model Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Model Market, By Application

8.1. Animal Model Market, by Application, 2024-2033

8.1.1 Cancer

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Immunological Disease

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Infectious Disease

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Animal Model Market, By Animal Type

9.1. Animal Model Market, by Animal Type, 2024-2033

9.1.1. Mice

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Rat

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Guinea Pigs

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Rabbits

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Hamsters

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Animal Model Market, By End-use 

10.1. Animal Model Market, by End-use, 2024-2033

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Academic Research Institute

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Contract Research Organization

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Animal Model Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 12. Company Profiles

12.1. Charles River Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. The Jackson Laboratory

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. genOway

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Taconic Biosciences, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Janvier Labs

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Harbour BioMed

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Crown Bioscience

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Inotiv

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. BIOCYTOGEN

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BioSpherix, Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *